INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 99 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $68,000 | +4.6% | 10,111 | -10.2% | 0.00% | 0.0% |
Q3 2015 | $65,000 | -31.6% | 11,258 | -3.3% | 0.00% | -25.0% |
Q2 2015 | $95,000 | -21.5% | 11,646 | -21.4% | 0.00% | 0.0% |
Q1 2015 | $121,000 | -12.9% | 14,826 | -2.1% | 0.00% | 0.0% |
Q4 2014 | $139,000 | – | 15,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Triatomic Management LP | 235,000 | $405,000 | 0.23% |
Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
Keystone Financial Group | 74,058 | $128,000 | 0.03% |
Virtu Financial LLC | 130,829 | $226,000 | 0.02% |